Volume 15, number 3
 PDF Downloads: 1590

Extraction, Identification and Pharmacological Evaluation of Phyto-Active Compound in Manilkara Hexandra (Roxb.) Dubard Stem Bark

S. Irudaya Monishaand J. Rosaline Vimala

Research Department of Chemistry, Holy Cross College, Affiliated to Bharathidasan University, Tiruchirapalli, Tamil Nadu - 620 002, India.

Corresponding Author E-mail: irudaya.monisha@gmail.com

DOI : http://dx.doi.org/10.13005/bbra/2677

ABSTRACT: Plants are made up of chemicals of differing nature produced by metabolism. These phytochemicals show varied biological activity. The present work was aimed to identify such active principle present in the stem bark of Manilkara hexandra (Roxb.)Dubard. Proximate, fluorescence, histochemical, mineral analysis was carried out for the plant material. From the preliminary analysis, the flavonoid rich extract was identified which was then subjected to using chromatographic methods for compound separation. Characterization of the separated compound was done by UV, FT-IR, and GC-MS studies. 7,9- DI-TERT-BUTYL-1-OXASPIRO[4.5]DECA-6,9-DIENE-2,8-DIONE was identified by GC-MS analysis. Antibacterial activity was carried and it shows high zone of inhibition, when concentration increases from 30 to 150 μg/ml. The separated flavanoid in future could be used to study its wide pharmacological applications as a lead compound in drug delivery.

KEYWORDS: Fluorescence; Histochemical; Manilkara Hexandra; Mineral Analysis Proximate

Download this article as: 
Copy the following to cite this article:

Monisha S. I, Vimala J. R. Extraction, Identification and Pharmacological Evaluation of Phyto-Active Compound in Manilkara Hexandra (Roxb.) Dubard Stem Bark. Biosci Biotech Res Asia 2018;15(3).

Copy the following to cite this URL:

Monisha S. I, Vimala J. R. Extraction, Identification and Pharmacological Evaluation of Phyto-Active Compound in Manilkara Hexandra (Roxb.) Dubard Stem Bark. Biosci Biotech Res Asia 2018;15(3). Available from: https://www.biotech-asia.org/?p=31070

[ HTML Full Text]

Back to TOC